FLXD:F:F-Franklin European Quality Dividend UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 28.27

Change

0.00 (0.00)%

Market Cap

N/A

Volume

7.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.10 (-0.20%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

+2.94 (+0.50%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.47B
VUSA:F Vanguard Funds Public Limited ..

+0.31 (+0.29%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.52 (+0.49%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.89B
0ZC:F Zscaler Inc

-0.46 (-0.24%)

USD 37.92B

ETFs Containing FLXD:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.71% 54% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.71% 52% F 55% F
Trailing 12 Months  
Capital Gain 11.85% 51% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.85% 47% F 51% F
Trailing 5 Years  
Capital Gain 14.76% 44% F 54% F
Dividend Return 18.83% 79% B- 49% F
Total Return 33.59% 61% D- 55% F
Average Annual (5 Year Horizon)  
Capital Gain 5.56% 56% F 57% F
Dividend Return 5.56% 54% F 51% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.66% 64% D 88% B+
Risk Adjusted Return 52.16% 60% D- 69% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike